Treatment toxicity constrains the use of effective cancer therapies, but its clinical and genetic determinants remain poorly defined. We developed a large language model-based approach to produce MSK-Tox, a pan-cancer resource capturing the incidence, temporality, and grade of toxicity to anti-cancer therapy across more than 50,000 patients. Analysis of six representative adverse events - pneumonitis, adrenal insufficiency, liver toxicity, colitis, hyperthyroidism and hypothyroidism - revealed distinct toxicity landscapes shaped by cancer type, treatment regimen, and clinical context.
Population-Scale Precision Safety in Oncology Reveals Clinical and Genetic Determinants of Systemic Therapy Toxicity
calendar_today
September 17, 2026
person
Bakouny, Z., Guo, X. A., Huang, F., Mohan, S., Walser, R., Lu, Z., Perea-Chamblee, T., Khan, L., Ahmed, N., Ocejo, A., Hakimi, A. A., Shah, N., Voss, M. H., Arbour, K. C., Cheung, Y.-M. M., Azhari, H., Faleck, D. M., Niec, R., Donoghue, M. T. A., Orgera, J. J., Syed, A., Berger, M. F., Waters, M., Pichotta, K., Fong, C., Jee, J., Schultz, N., Schrag, D., Yarmus, L., Schoenfeld, A. J., Gusev, A., Kotecha, R. R., Motzer, R. J., Thompson, C. B., Tansey, W., Carrot-Zhang, J., Reznik, E.
domain
medrxiv